Company

We are the pioneering new drug development company, specializing in brain immunity. Our primary focus is on developing treatments for intractable brain diseases associated with aging, utilizing an innovative platform technology that rejuvenates brain immunity-related cells, microglia.

Mission

Brainimmunex's mission is to develop brain immunity-rejuvenating therapeutics for age-related CNS diseases. To achieve this goal, we employ an interdisciplinary approach to address challenging brain diseases, including Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), Parkinson’s diseases, and Glioblastoma multiforme.

Strategy

1. Core Platform strategy

- Dedication to continuous efforts for innovation

2. Business scale up strategy

- Pipeline expansion

3. Sustainable business model

- Build and diversify product line step by step